Physician profile
Joyce E Samuel
NPI 1902057284
$1,490.63
in general payments reported to CMS, 2019-2025
17 companies · $1,234 in 2025
The $1,234 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $257 · 2025: $1,234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,490.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $318.90 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $271.74 | 2024-2025 | Entyvio, Eohilia, Gattex |
| Celltrion USA INC. | $210.84 | 2025 | Vegzelma |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $106.57 | 2025 | Xifaxan |
| Acera Surgical, INC. | $92.45 | 2025 | Restrata Wound Matrix |
| Lilly USA, LLC | $86.57 | 2024-2025 | Omvoh |
| Janssen Biotech, INC. | $72.40 | 2025 | Tremfya |
| Phathom Pharmaceuticals, INC. | $53.74 | 2025 | Voquezna |
| Genzyme Corporation | $52.88 | 2025 | |
| Medtronic, INC. | $46.62 | 2025 | Signia |
| Novo Nordisk INC | $37.34 | 2025 | Wegovy |
| Regeneron Healthcare Solutions, INC. | $35.77 | 2024 | Dupixent |
| Mallinckrodt Hospital Products INC. | $30.67 | 2025 | Terlivaz |
| Ethicon US, LLC | $21.16 | 2025 | Enseal |
| Braintree Laboratories, INC. | $19.43 | 2025 | Suflave, Sutab |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blueprint Medicines Corporation | $17.20 | 2024 | Ayvakit |
| Ipsen Biopharmaceuticals, INC | $16.35 | 2025 | Iqirvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Samuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.